LACQUANITI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 2.542
EU - Europa 1.995
AS - Asia 600
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.145
Nazione #
US - Stati Uniti d'America 2.536
IE - Irlanda 687
SE - Svezia 629
CN - Cina 469
IT - Italia 209
DE - Germania 115
FI - Finlandia 100
GB - Regno Unito 69
IN - India 69
UA - Ucraina 69
SG - Singapore 54
FR - Francia 33
BE - Belgio 29
PL - Polonia 24
CZ - Repubblica Ceca 12
AU - Australia 5
CA - Canada 5
RU - Federazione Russa 5
NL - Olanda 4
ES - Italia 2
EU - Europa 2
IL - Israele 2
IS - Islanda 2
RO - Romania 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CH - Svizzera 1
GR - Grecia 1
IQ - Iraq 1
IR - Iran 1
KR - Corea 1
LV - Lettonia 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 5.145
Città #
Dublin 687
Chandler 587
Nyköping 326
Jacksonville 225
Beijing 194
New York 158
Ashburn 147
Dearborn 128
Ann Arbor 119
Princeton 103
Medford 101
Cambridge 97
Messina 86
Des Moines 72
Boardman 54
Bremen 46
Jinan 44
San Mateo 44
Houston 42
Shenyang 38
Pune 35
Lancaster 34
Hyderabad 31
Singapore 28
Wilmington 28
Brussels 27
Woodbridge 25
Hebei 24
Warsaw 24
Lentini 22
Nanjing 22
Seattle 17
Ningbo 15
Hangzhou 14
Zhengzhou 13
Nanchang 12
Haikou 11
Jiaxing 11
Tianjin 11
Brno 9
Munich 9
Falls Church 8
Norwalk 8
Los Angeles 7
Rome 7
Tappahannock 7
Fuzhou 6
Taiyuan 6
Taizhou 6
Guangzhou 5
Hefei 5
Lanzhou 5
Sydney 5
Augusta 4
Changsha 4
Leawood 4
Auburn Hills 3
Brescia 3
Lappeenranta 3
Milan 3
Olomouc 3
Redwood City 3
Siracusa 3
Washington 3
Amsterdam 2
Cesena 2
Dong Ket 2
Kopavogur 2
Liège 2
Monmouth Junction 2
Montréal 2
Naples 2
Ottawa 2
Palermo 2
Paris 2
Saint Petersburg 2
Saint-Fons 2
Soverato 2
Yicheng 2
Baton Rouge 1
Bilgi 1
Brasov 1
Bratislava 1
Brooklyn 1
Chengdu 1
Chicago 1
Chieti 1
Clearwater 1
Columbus 1
Cupertino 1
Eden Prairie 1
Edinburgh 1
Eschweiler 1
Foggia 1
Frankfurt Am Main 1
Frankfurt am Main 1
Helsinki 1
Irving 1
Jerusalem 1
Kemerovo 1
Totale 3.882
Nome #
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 107
Emerging markers of cachexia predict survival in cancer patients. 88
3 Tesla-Diffusion Tensor Imaging in Autosomal Dominant Polycystic Kidney Disease: The Nephrologist's Point of View 83
Both IL-1β and TNF-α Regulate NGALExpression in Polymorphonuclear Granulocytes ofChronic Hemodialysis Patients 83
Acute pulmonary exacerbation and lung function decline in patients with cystic fibrosis: high-mobility group box 1 (HMGB1) between inflammation and infection. 79
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 79
Sclerostin levels in uremic patients: a link between bone and vascular disease 79
Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation 78
Central precocious puberty: from physiopathological mechanisms to treatment. 76
Dialysis and the Elderly: An Underestimated Problem. 76
[From oxygen to erythropoietin, as a protagonist of the skin-brain-kidney axis]. 76
High mobility group box 1 and tumor growth factor β: useful biomarkers in pediatric patients receiving peritoneal dialysis 73
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 72
The erythropoietin and regenerative medicine: a lesson from fish 71
La Genotossicità nel Paziente Uremico: un modello di studio sorprendente. 71
Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment. 66
The concept of the urine test and specific reaction of the urine in various diseases according to Enrico Cauchi - member of the medical council of Malta (1933) 66
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression 66
Before and after preeclampsia: What biomarkers are there? 64
Fibrosis, regeneration and cancer: what is the link? 63
A new therapy for kidney injury: regeneration. 63
Thalassaemia major and infectious risk: High Mobility Group Box-1 represents a novel diagnostic and prognostic biomarker 63
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R). 62
Erythropoietin and the truths of science. 62
Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? 59
Malnutrition in the elderly patient on dialysis. 59
Sevalamer Hydrochloride, Sevelamer Carbonate and Lanthanum Carbonate: In Vitro and In Vivo Effects on Gastric Environment 58
Down with the erythropoietin. Long live the erythropoietin! 58
Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: Serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment 58
[From hyponatremia to tolvaptan] 57
Kidney disease and psoriasis: novel evidences beyond old concepts 57
Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis 56
Renal complications in oncohematologic patients. 56
Kidney-lung connections in acute and chronic diseases: current perspectives 56
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. 55
Hydrocarbons and kidney damage: Potential use of neutrophil gelatinase-associated lipocalin and sister chromatide exchange 55
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. 55
"Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL. 55
Pseudotumor cerebri syndrome and renal diseases in the pediatric population 55
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease 54
Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients 54
The Myth of Water and Salt: From Aquaretics to Tenapanor 54
Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy? 54
From chronic kidney disease to transplantation: the roles of obestatin. 53
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 53
Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function 52
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 52
Apelin, Plasmatic Osmolality and Hypotension in Dialyzed Patients. 52
Salt-water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin 52
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and progression of chronic kidney disease. 51
Squilibri idrico-salini e sovraccarico di liquidi nei pazienti dializzati, il ruolo centrale di Corin 51
Transient diabetes insipidus in pregnancy, diagnostic role of apelin and copeptin: A case report 51
High-mobility group protein B1: a new biomarker of metabolic syndrome in obese children 49
From water to aquaretics: a legendary route. 49
New options for the management of polycystic kidney disease 49
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide. 49
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study 49
High-mobility group box 1 in allergic and non allergic upper airway inflammation 48
Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure 47
Vitamin D intoxication in two brothers: be careful with dietary supplements. 47
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease 47
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 47
Non-Invasive Imaging for Evaluating Cardiovascular Involvement in Patients with Primary and Lupus Nephritis. 47
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. 46
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Endothelial Progenitor Cells (EPCs) Evaluation in Aortic Aneurysm Repair. 46
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 46
A Biotechnological T-Shirt Monitors the Patient's Heart during Hemodialysis. 45
Obestatin: a new element for mineral metabolism and inflammation in patients on hemodialysis. 43
Serum levels of Apelin-36 are decreased in older hospitalized patients with heart failure 43
Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease 43
Persistent left superior vena cava and partially left inferior vena cava: A case report of a dangerous central venous catheterization 43
Regenerative medicine: does Erythropoietin have a role? 43
Renal biopsy: Still a landmark for the nephrologist 42
Serum levels of apelin-36 are decresed in elderly hospitalized patients with heart failure 41
Proteinuric effect of transcranial magnetic stimulation in healthy subjects and diabetic patients with stage 3-4 CKD 40
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 40
Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study 40
Regeneration and the Plant We have Inside 40
NGAL is a precocious marker of therapeutic response. 39
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. 39
Obestatin: an interesting but controversial gut hormone. 39
NGAL as an early biomarker of kidney disease in Joubert syndrome: three brothers compared. 39
QUANTITATIVE ULTRASOUND OF BONE AND HANDGRIP STRENGTH ARE RELATED TO FRACTURE RISK IN HEMODIALYSIS PATIENTS 39
Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide 37
Prolactin in obese children: a bridge between inflammation and metabolic-endocrine dysfunction 36
Does Erythropoietin Always Win? 35
Increase in creatinine for the prediction of contrast-induced nephropathy 35
New available biomarkers to face a worldwide emergency: The childhood obesity 35
Real-time monitoring of breath ammonia during haemodialysis: use of ion mobility spectrometry (IMS) and cavity ring-down spectroscopy (CRDS) techniques. 31
Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients 30
null 30
Apelin and copeptin: two opposite biomarkers associated with kidney function decline and cyst growth in autosomal dominant polycystic kidney disease 30
Neutrophil gelatinase-associated lipocalin in the intensive care unit: time to look beyond a single, threshold-based measurement? 27
Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients. 27
The future of phosphate binders: a perspective on novel therapeutics 27
[Tolvaptan and autosomal dominant polycystic kidney disease in the adult: let's give time to the "TEMPO" trial (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes)] 26
Thyroid dysfunction in thalassaemic patients: ferritin as a prognostic marker and combined iron chelators as an ideal therapy 25
LMNA gene mutation as a model of cardiometabolic dysfunction: From genetic analysis to treatment response. 24
Erythropoiesis and chronic kidney disease–related anemia: From physiology to new therapeutic advancements 24
Neutrophil gelatinase-associated lipocalin in peritoneal dialysis reflects status of peritoneum. 24
Totale 5.165
Categoria #
all - tutte 21.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.433


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020636 33 11 8 10 11 136 81 69 27 148 83 19
2020/2021592 55 26 159 30 76 51 21 13 23 69 42 27
2021/2022789 6 88 11 46 40 7 53 40 9 173 86 230
2022/20232.048 146 229 95 149 176 197 14 127 849 11 38 17
2023/2024626 33 70 22 53 49 259 7 22 8 37 7 59
2024/202536 36 0 0 0 0 0 0 0 0 0 0 0
Totale 5.293